Esperion Therapeutics, Inc.·4

Feb 20, 4:50 PM ET

Warren Eric 4

4 · Esperion Therapeutics, Inc. · Filed Feb 20, 2025

Insider Transaction Report

Form 4
Period: 2025-02-19
Warren Eric
Chief Commercial Officer
Transactions
  • Sale

    Common Stock

    2025-02-19$1.87/sh239$446159,759 total
Footnotes (1)
  • [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.

Documents

2 files